Video Experimental Relacionado
Updated: Mar 2, 2026
19:53
Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
Published on: March 1, 2015
106.6K
Parálisis Flácida Aguda
Amanda M Dave1,2, Kyoko Fukahori1,3, Meghan Mack1,3
1University of Pittsburgh Medical Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Pediatrics in review
|February 28, 2026
Resumen
La parálisis flácida aguda implica debilidad repentina de diversas causas, como infecciones o afecciones autoinmunes. Un manejo eficaz requiere un enfoque integral y multidisciplinario para el tratamiento y la rehabilitación.
Área de la Ciencia:
- Neurología
- Inmunología
- Enfermedades Infecciosas
Sus antecedentes:
- La parálisis flácida aguda (PFA) es un síndrome clínico crítico caracterizado por el inicio repentino de debilidad muscular.
- La PFA puede derivar de diversas etiologías, que abarcan trastornos autoinmunes, infecciones virales y afecciones neurológicas primarias.
- El diagnóstico y la intervención rápidos son cruciales para el manejo de la PFA y la prevención de secuelas a largo plazo.
Objetivo del estudio:
- Revisar las causas multifacéticas de la parálisis flácida aguda.
- Esbozar las estrategias actuales de manejo de la PFA.
- Enfatizar la importancia de un enfoque multidisciplinario en la atención de la PFA.
Principales métodos:
- Revisión de la literatura de estudios sobre parálisis flácida aguda.
- Análisis de los factores etiológicos que contribuyen a la PFA.
- Síntesis de los protocolos de tratamiento y rehabilitación.
Principales resultados:
- La parálisis flácida aguda se presenta con debilidad muscular rápida.
- Las causas identificadas incluyen enfermedades autoinmunes, infecciones virales y trastornos neurológicos.
- La atención de apoyo es la piedra angular del manejo.
Conclusiones:
- El manejo de la parálisis flácida aguda es principalmente de apoyo.
- Un equipo multidisciplinario es esencial para optimizar los resultados del tratamiento y la rehabilitación.
- La atención temprana y coordinada mejora el pronóstico del paciente en la PFA.
Palabras clave:
Parálisis flácida agudaDebilidad muscularEnfermedades autoinmunesInfeccionesManejo multidisciplinarioRehabilitaciónMás Videos Relacionados
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
33.4K
08:11Assessing Forelimb Function after Unilateral Cervical SCI using Novel Tasks: Limb Step-alternation, Postural Instability and Pasta Handling
Published on: September 16, 2013
22.6K
Videos de Conceptos Relacionados
01:26Chemical Synapses
12.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.1K
01:26Chemical Synapses
5.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
5.2K
01:28Disorders of the Skeletal Muscle
2.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K
01:28Classification of Skeletal Muscle Relaxants
3.2K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.2K
01:28Depolarizing Blockers: Mechanism of Action
3.2K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
3.2K
01:15Myasthenia Gravis: Diagnostic Tests
2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K